Antibiotics for Orchitis
For orchitis in men under 35 years, treat empirically with ceftriaxone 1 g IM/IV plus doxycycline 100 mg twice daily for 7-10 days to cover both gonorrhea and chlamydia; for men over 35 years with suspected enteric pathogens, use a fluoroquinolone (levofloxacin 500 mg daily) or trimethoprim-sulfamethoxazole for 10-14 days.
Age-Based Treatment Algorithm
Men Under 35 Years (Sexually Transmitted Pathogens)
The primary pathogens are Chlamydia trachomatis and Neisseria gonorrhoeae 1, 2. The most recent European guidelines (2024) recommend ceftriaxone 1 g IM or IV as a single dose plus azithromycin 1 g orally as a single dose for gonococcal coverage 3. However, for orchitis specifically (versus simple urethritis), extended therapy is warranted.
Recommended regimen:
- Ceftriaxone 1 g IM or IV (single dose for gonorrhea) 3
- PLUS Doxycycline 100 mg orally twice daily for 7-10 days (for chlamydia and extended coverage) 1, 2
Alternative if doxycycline contraindicated:
- Azithromycin 1 g orally single dose 3, though this provides less sustained tissue levels for orchitis
Critical caveat: Quinolones (ciprofloxacin, ofloxacin) are no longer recommended for gonorrhea due to widespread resistance 4, 3. The older CDC guidelines from 1993-2002 that suggested quinolones are outdated 5, 6.
Men Over 35 Years (Enteric Pathogens)
The primary pathogens are Enterobacteriaceae (E. coli, Klebsiella), often associated with urinary tract abnormalities or bladder outlet obstruction 1, 2, 7.
Recommended regimen for moderate symptoms (outpatient):
- Levofloxacin 500 mg orally daily for 10-14 days 2
- OR Trimethoprim-sulfamethoxazole (double strength) twice daily for 10-14 days 1
For severe symptoms requiring hospitalization:
- Aminoglycoside (gentamicin) plus cephalosporin (ceftriaxone) IV initially 1
- Transition to oral fluoroquinolone or trimethoprim-sulfamethoxazole based on culture results
Important consideration: Rising fluoroquinolone resistance in E. coli means empiric coverage should be guided by local resistance patterns 7. If ciprofloxacin resistance exceeds 10% locally, consider alternative agents or await culture results.
Key Clinical Distinctions
Look for these features to guide age-based treatment:
- Sexual history: Multiple partners, new partner, or STI exposure → treat as STI-related regardless of age
- Urinary symptoms: Dysuria, frequency, prior UTIs → suggests enteric pathogens
- Urethral discharge: Purulent discharge strongly suggests gonorrhea
- Recent instrumentation: Catheterization, cystoscopy → enteric pathogens more likely
Diagnostic Testing Before Treatment
While empiric therapy is often initiated, obtain urethral swab or first-void urine for NAAT testing for C. trachomatis and N. gonorrhoeae 3, 2. For men over 35, obtain urine culture to guide antibiotic selection 1, 2.
If gonorrhea is confirmed, perform culture with susceptibility testing to monitor for resistance 3.
Treatment Duration Rationale
Standard urethritis treatment is 7 days, but orchitis requires longer therapy (10-14 days minimum) due to poor antibiotic penetration into testicular tissue 1. Some sources recommend up to 3 weeks for severe cases 1.
Partner Management
Sexual partners within the preceding 60 days must be evaluated and treated presumptively for STI-related orchitis 3, 1. This is critical to prevent reinfection and ongoing transmission.
Common Pitfalls to Avoid
- Do not use quinolones for suspected gonorrhea - resistance is too widespread 4, 3
- Do not treat with ceftriaxone alone - chlamydia coinfection occurs in 15-26% of gonorrhea cases 8
- Do not use short courses - orchitis requires extended therapy compared to simple urethritis
- Do not assume age alone determines pathogen - sexual history trumps age in pathogen prediction
When to Hospitalize
Admit for IV antibiotics if:
- Severe systemic symptoms (high fever, sepsis)
- Inability to tolerate oral medications
- Suspected abscess formation
- Failed outpatient therapy